ListedMainboardCONCORDBIO
Concord Biotech Limited
Concord Biotech Limited is a mainboard IPO raising ₹1,551 Cr at ₹705 – ₹741 a share. It listed on 18 Aug 2023 and trades at ₹1,255 today, +69.4% against its issue price of ₹741. It was subscribed 25× in total.
₹741
Issue price
₹1,255
Price now
+69.4%
Since issue price
18 Aug 2023
Listed on
25×Subscribed (final) · all exchanges
24.9 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Lead managers, and how their past issues have done
Median return since issue price across every IPO we hold this bank on. Not a forecast for this issue — a record.
| Lead manager | IPOs we hold them on | Of which we can price | Median return since issue |
|---|---|---|---|
| Kotak Mahindra Capital Company Limited | 77 | 68 | +24.6% |
| Citigroup Global Markets India Private Limited | 34 | 33 | +32.5% |
| Jefferies India Private Limited | 27 | 23 | +40.6% |
A bank appears on an issue we can price only when the company is matched to our price history, so the two counts differ. See the full league table →
Registrar
Contact them about allotment, refunds or unblocking your application amount — not the company, and not the exchange.
NameLink Intime India Private Limited
ContactShanti Gopalkrishnan
Emailconcordbiotech.ipo@linkintime.co.in
Phone+91 022 4918 6200
Websitehttps://linkintime.co.in/ ↗